1.The role of hepatocyte cytochrome P450 1A1, 2E1 in rat nonalcoholic steatosis
Hongtao SHI ; Dongfeng CHEN ; Renping XIONG ; Al ET ;
Chinese Journal of Digestion 1998;0(06):-
Objective To detect the expression of hepatocyte cytochrome P450 1A1,2E1 in rat non alcoholic steatosis model. Methods 7 ethoxyresorufin O deethylase (EROD) and benzopyrene hydroxylase (ANH) activity were determined by ultraviolet chromatography. The expression of hepatocyte cytochrome P450 1A1, 2E1 protein in the liver of rats with non alcoholic steatosis induced by high fat diet was detected with immunohistochemistry and Western blot. Cytochrome P450 1A1, 2E1 mRNA were assayed with reverse transcriptase polymerase chain reaction(RT PCR). Results The levels of EROD activity in nonalcoholic steatosis rat at 2, 4, 8, 12 week and normal control group were (325.07?59.68),(345.25?49.28),( 468.95 ?55.28),( 548.68 ?43.25) and (260.42?35.32) nmol?mg -1 ?min -1 respectively. The levels of ANH activity in nonalcoholic steatosis rat at 2, 4, 8, 12 week and normal control group were (635.68 ?65.48), (735.45 ?76.89 ),(887.45?85.65),(956.58?84.47) and (500.25?78.34) nmol?mg -1 ?min -1 respectively. These indicate that the levels of EROD and ANH activity in rats with nonalcoholic steatosis were significantly increased compared with that in control group. In addition, the expression of hepatocyte cytochrome P450 1A1, 2E1 protein and cytochrome P450 1A1, 2E1 mRNA in rats with nonalcoholic steatosis were significantly higher than that in control group. The level of P450 1A1 and 2E1 was increased correspondingly with the degree of nonalcoholic steatosis. Conclusions The induction of hepatocyte cytochrome P4501A1 and 2E1 might participate in the development of nonalcoholic steatosis
2.Protecting mechanism of heat stress in treatment of acute lung injury
Min ZHANG ; Renping XIONC ; Xingyun CHEN ; Yan ZHAO ; Ping LI ; Ping LIU ; Yuanguo ZHOU
Chinese Journal of Trauma 2008;24(6):465-469
Objective To investigate the protecting mechanism of heat stress pretreatment on acute lung injury(ALI). Methods The oleic acid ALI mouse model was built to dynamically observe the binding capacity and the binding affinity of glucocorticoid receptor(GR),the levels of GR,heat shock protein 90(Hsp90)and Hsp70 before and after hyperthermic stress pretreatment. Results Heat stress pretreatment had significant protective effect on ALI.Western blotting showed insignificant changes of GR levels but progressive increase of level of Hsp70 and Hsp90.Heat stress pretreatment exerted insignificant effect on Bmax and Kd of GR,shown by radio ligand binding assay after ALI. Conclusion The protective effects of heat stress pretreatment on ALI of mouse may relate to its ability of keeping stable GR level and increasing levels of Hsp70 and Hsp90.
3.Mechanism of dexamethasone inhibiting U937 cell adhesion and phagocytose function
Dong LIU ; Xingyun CHEN ; Renping XIONG ; Ping LI ; Yalei NING ; Yan PENG ; Yan ZHAO ; Nan YANG ; Yuanguo ZHOU
Chinese Journal of Trauma 2012;28(5):466-469
ObjectiveTo investigate the mechanism of dexamethasone (Dex) in inhibiting monocyte adhesion and phagocytose function.Methods Under the stimulation of phorbo1-12-myristate-13-acetate (PMA),U937 monocytes cultured in vitro were treated with Dex and Fasudil respectively.The adhesion rate of U937 monocles to human umbilical vein endothelial cells (HUVECs) and their phagocytic ability of India ink were studied.The protein content and activity of rho-associated coiled-coil protein kinase 1 ( ROCK1 ) as well as the effects of mifepristone and cycloheximide on Dex were determined.ResultsBoth DEX and Fasudil could significantly inhibit the adhesion tate and phagocytosis of U937 cells stimulated by PMA and suppressed the activity of ROCK1.While mifepristone and cycloheximide could not alter these effects of DEX.ConclusionDEX interferes with the adhesion and phagocytosis function of U937 cells by inhibiting ROCKI activity.
4. A Study on the establishment of immune thrombocytopenia model induced by anti-platelet GPⅠbα antibodies
Kangxi ZHOU ; Rong YAN ; Mengxing CHEN ; Jun LIU ; Qingya CUI ; Renping HU ; Yancai LIU ; Yang ZHANG ; Changgeng RUAN ; Kesheng DAI
Chinese Journal of Hematology 2017;38(5):390-393
Objective:
To establish primary immune thrombocytopenia (ITP) animal model induced by anti-platelet membrane glycoprotein GPⅠbα antibodies AN51 and R300.
Methods:
Twenty guinea pigs (6-8 week) were divided into 4 groups. Five guinea pigs in each group were intravenously injected with different doses of AN51 (0.05, 0.1, 0.2 μg/g) and 0.2 μg/g IgG as control. The whole blood was collected from inner angular venous plexus. Platelets number was determined by an automated cell counter and Swiss-Jim method. Then, the similar protocol was used to establish ITP nude mice model by intraperitoneal injection of different concentrations of anti-platelet GPⅠbα antibody R300, respectively.
Results:
①Five minutes after intravenous injection of AN51 at 0.05, 0.1 and 0.2 μg/g, the platelet counts of guinea pigs reduced about 0-5%, 50%-60% and 70%-80% compared to the control group, respectively. The difference was statistically significant (
5.Determination of Main Components and Related Substances in Phenzolzine Capsules by HPLC
Yinghua ZHANG ; Jia GAO ; Renping CHEN ; Wei LIU ; Qing WANG ; Weiyu ZHANG
China Pharmacy 2019;30(19):2613-2617
OBJECTIVE: To establish a method for content determination of main components and its related substances in Phenzolzine capsules. METHODS: HPLC method was adopted for content determination of main components. The contents of related substance (known impurity 1, known impurity 2, total impurity) were calculated with principle component self-control method. The determination was performed on Inertsil ODS-2 C18 column with mobile phase consisted of acetonitrile-water (55 ∶ 45, V/V)at the flow rate of 1.0 mL/min. The detection wavelength was set at 223 nm, and column temperature was 25 ℃. The sample size was 20 μL. RESULTS: The main component phenzolzine and other impurity peaks were well separated. The liner range of phenzolzine was 20.04-60.12 μg/mL (r=1.000 0). RSDs of precision, stability (24 h) and reproducibility tests were all ≤0.5% (n=6). Average recovery was 97.50% (RSD=0.36%, n=3). The detection limit and quantification limit of phenzolzine were 0.91 ng and 3.04 ng. In 3 batches of samples, average value of phenzolzine, known impurity 1, known impurity 2 and total impurity were 106.68%, 0.002 1%, 0.044 0% and 0.046 2%, respectively. CONCLUSIONS: Established method is simple, specific, sensitive and accurate for content determination of main component and related substance in Phenzolzine capsules. It is suitable for quality control of Phenzolzine capsules.
6.Alterations of β-γ coupling of scalp electroencephalography during epilepsy.
Kaijie LI ; Junfeng LU ; Renping YU ; Rui ZHANG ; Mingming CHEN
Journal of Biomedical Engineering 2023;40(4):700-708
Uncovering the alterations of neural interactions within the brain during epilepsy is important for the clinical diagnosis and treatment. Previous studies have shown that the phase-amplitude coupling (PAC) can be used as a potential biomarker for locating epileptic zones and characterizing the transition of epileptic phases. However, in contrast to the θ-γ coupling widely investigated in epilepsy, few studies have paid attention to the β-γ coupling, as well as its potential applications. In the current study, we use the modulation index (MI) to calculate the scalp electroencephalography (EEG)-based β-γ coupling and investigate the corresponding changes during different epileptic phases. The results show that the β-γ coupling of each brain region changes with the evolution of epilepsy, and in several brain regions, the β-γ coupling decreases during the ictal period but increases in the post-ictal period, where the differences are statistically significant. Moreover, the alterations of β-γ coupling between different brain regions can also be observed, and the strength of β-γ coupling increases in the post-ictal period, where the differences are also significant. Taken together, these findings not only contribute to understanding neural interactions within the brain during the evolution of epilepsy, but also provide a new insight into the clinical treatment.
Humans
;
Scalp
;
Epilepsy/diagnosis*
;
Brain
;
Electroencephalography
7.Clinical treatment guideline for pulmonary blast injury (version 2023)
Zhiming SONG ; Junhua GUO ; Jianming CHEN ; Jing ZHONG ; Yan DOU ; Jiarong MENG ; Guomin ZHANG ; Guodong LIU ; Huaping LIANG ; Hezhong CHEN ; Shuogui XU ; Yufeng ZHANG ; Zhinong WANG ; Daixing ZHONG ; Tao JIANG ; Zhiqiang XUE ; Feihu ZHOU ; Zhixin LIANG ; Yang LIU ; Xu WU ; Kaican CAI ; Yi SHEN ; Yong SONG ; Xiaoli YUAN ; Enwu XU ; Yifeng ZHENG ; Shumin WANG ; Erping XI ; Shengsheng YANG ; Wenke CAI ; Yu CHEN ; Qingxin LI ; Zhiqiang ZOU ; Chang SU ; Hongwei SHANG ; Jiangxing XU ; Yongjing LIU ; Qianjin WANG ; Xiaodong WEI ; Guoan XU ; Gaofeng LIU ; Junhui LUO ; Qinghua LI ; Bin SONG ; Ming GUO ; Chen HUANG ; Xunyu XU ; Yuanrong TU ; Liling ZHENG ; Mingke DUAN ; Renping WAN ; Tengbo YU ; Hai YU ; Yanmei ZHAO ; Yuping WEI ; Jin ZHANG ; Hua GUO ; Jianxin JIANG ; Lianyang ZHANG ; Yunfeng YI
Chinese Journal of Trauma 2023;39(12):1057-1069
Pulmonary blast injury has become the main type of trauma in modern warfare, characterized by externally mild injuries but internally severe injuries, rapid disease progression, and a high rate of early death. The injury is complicated in clinical practice, often with multiple and compound injuries. Currently, there is a lack of effective protective materials, accurate injury detection instrument and portable monitoring and transportation equipment, standardized clinical treatment guidelines in various medical centers, and evidence-based guidelines at home and abroad, resulting in a high mortality in clinlcal practice. Therefore, the Trauma Branch of Chinese Medical Association and the Editorial Committee of Chinese Journal of Trauma organized military and civilian experts in related fields such as thoracic surgery and traumatic surgery to jointly develop the Clinical treatment guideline for pulmonary blast injury ( version 2023) by combining evidence for effectiveness and clinical first-line treatment experience. This guideline provided 16 recommended opinions surrounding definition, characteristics, pre-hospital diagnosis and treatment, and in-hospital treatment of pulmonary blast injury, hoping to provide a basis for the clinical treatment in hospitals at different levels.
8.Pharmaceutical care for severe and critically ill patients with COVID-19.
Saiping JIANG ; Lu LI ; Renping RU ; Chunhong ZHANG ; Yuefeng RAO ; Bin LIN ; Rongrong WANG ; Na CHEN ; Xiaojuan WANG ; Hongliu CAI ; Jifang SHENG ; Jianying ZHOU ; Xiaoyang LU ; Yunqing QIU
Journal of Zhejiang University. Medical sciences 2020;49(2):158-169
Severe and critically ill patients with coronavirus disease 2019 (COVID-19) were usually with underlying diseases, which led to the problems of complicated drug use, potential drug-drug interactions and medication errors in special patients. Based on ( 6), and -19: , we summarized the experience in the use of antiviral drugs, corticosteroids, vascular active drugs, antibacterial, probiotics, nutrition support schemes in severe and critically ill COVID-19 patients. It is also suggested to focus on medication management for evaluation of drug efficacy and duration of treatment, prevention and treatment of adverse drug reactions, identification of potential drug-drug interactions, individualized medication monitoring based on biosafety protection, and medication administration for special patients.
Adrenal Cortex Hormones
;
adverse effects
;
therapeutic use
;
Anti-Bacterial Agents
;
therapeutic use
;
Antiviral Agents
;
adverse effects
;
therapeutic use
;
Betacoronavirus
;
isolation & purification
;
Coronavirus Infections
;
drug therapy
;
Critical Illness
;
Drug Therapy
;
Humans
;
Nutritional Support
;
Pandemics
;
Pneumonia, Viral
;
drug therapy
;
Probiotics
;
administration & dosage